Basic Study
Better to be alone than in bad company: The antagonistic effect of cisplatin and crizotinib combination therapy in non-small cell lung cancer

World J Clin Oncol
7(6):425-432.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.425
Abstract (1294)
|
Core Tip (1101)
|
Full Article (HTML) (3719)
|
Figures (1-2) (396)
|
Tables (1-2) (356)
|
Full Article (PDF)-2061K (454)
|
Audio-594K (61)
|
Peer-Review Report-120K (247)
|
Answering Reviewers-141K (288)
|
Received: 06/20/2016
|
Revised: 08/12/2016
|
Accepted: 10/27/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (8)
|
Total Visits (13403)
|
Similar Articles (98)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Study
World J Clin Oncol
7(6):433-440.
Published online Dec 10, 2016.
doi: 10.5306/wjco.v7.i6.433
Abstract (1279)
|
Core Tip (1229)
|
Full Article (HTML) (4044)
|
Figures (1-3) (727)
|
Tables (1-2) (414)
|
Full Article (PDF)-1143K (493)
|
Audio-1781K (22)
|
Peer-Review Report-120K (260)
|
Answering Reviewers-566K (339)
|
Received: 08/03/2016
|
Revised: 09/10/2016
|
Accepted: 10/18/2016
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (3)
|
Total Visits (16259)
|
Similar Articles (989)
|
Timeline of Article Publication (0)
|
Authors Evaluation (9)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open